Raymond Rosen
Affiliations: | Rutgers University, New Brunswick, New Brunswick, NJ, United States |
Area:
Clinical Psychology, OncologyGoogle:
"Raymond Rosen"Mean distance: 53433
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Derogatis LR, Revicki DA, Rosen RC, et al. (2021) Psychometric validation of the Female Sexual Distress Scale-Desire/Arousal/Orgasm. Journal of Patient-Reported Outcomes. 5: 100 |
Yafi FA, Huynh LM, Ahlering T, et al. (2020) What Is a "Validated Questionnaire"? A Critical Review of Erectile Function Assessment. The Journal of Sexual Medicine |
Roehrborn CG, Rosen RC, Manyak MJ, et al. (2020) Men's Sexual Health Questionnaire score changes versus spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a post hoc analysis of a prospective, randomised, placebo-controlled study. International Journal of Clinical Practice. e13480 |
McMahon C, Althof S, Rosen R, et al. (2019) The Oxytocin Antagonist Cligosiban Prolongs Intravaginal Ejaculatory Latency and Improves Patient-Reported Outcomes in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Trial (PEPIX). The Journal of Sexual Medicine. 16: 1178-1187 |
Fisher W, Sand M, Rosen R, et al. (2019) 011 Impact of ED, and Treatment of ED, on Female Sexual Function: Results of the Strike Up a Conversation, Females, and Partner Satisfaction Research Programs The Journal of Sexual Medicine. 16 |
Rosen RC, Roehrborn CG, Manyak MJ, et al. (2018) Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH): a post hoc analysis of a prospective randomized placebo-controlled study. International Journal of Clinical Practice. e13282 |
Wang C, Stephens-Shields AJ, DeRogatis LR, et al. (2018) Validity and Clinically Meaningful Changes in the Psychosexual Daily Questionnaire and Derogatis Interview for Sexual Function Assessment: Results From the Testosterone Trials. The Journal of Sexual Medicine. 15: 997-1009 |
Roehrborn CG, Manyak MJ, Palacios-Moreno JM, et al. (2017) A prospective randomised placebo-controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH). Bju International |
Derogatis LR, Sand M, Balon R, et al. (2016) Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part I. The Journal of Sexual Medicine |
Hatzichristou D, Kirana PS, Banner L, et al. (2016) Diagnosing Sexual Dysfunction in Men and Women: Sexual History Taking and the Role of Symptom Scales and Questionnaires. The Journal of Sexual Medicine. 13: 1166-82 |